National Cancer Institute; Notice of Closed Meetings, 28235 [2013-11345]

Agencies

• DEPARTMENT OF HEALTH AND HUMAN SERVICES
• National Institutes of Health

[Federal Register Volume 78, Number 93 (Tuesday, May 14, 2013)]
[Notices]
[Page 28235]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-11345]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Novel Imaging Agents to Expand the Clinical Toolkit for 
Cancer Diagnosis, Staging, and Treatment.
    Date: May 29, 2013.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, 9609 Medical Center Drive, 
Room 4W034, Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Sonya Roberson, Ph.D., Health Scientist 
Administrator, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W116, Bethesda, MD 20892-8328, 240-276-6347, 
robersos@mail.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting date due to scheduling conflicts.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Cancer Theranostics II.
    Date: June 3, 2013.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 9609 Medical Center Drive, 
Room 7W030, Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Savvas C Makrides, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W246, Bethesda, MD 20892-8328, 240-276-6374, 
makridessc@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Companion Diagnostics--Phase II.
    Date: June 5, 2013.
    Time: 10:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 9609 Medical Center Drive, 
Room 7W032, Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Adriana Stoica, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W234, Bethesda, MD 20892-8328, 240-276-6368, 
Stoicaa2@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Pharmacodynamic Assays TX2 of 2.
    Date: June 6, 2013.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, 9609 Medical Center Drive, 
Room 7W034, Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Thomas M Vollberg, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W102, Bethesda, MD 20892-8328, 240-276-6341, 
vollbert@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Biosensors for Early Cancer Detection and Risk Assessment.
    Date: June 10, 2013.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 9609 Medical Center Drive, 
Room 6W032, Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W244, Bethesda, MD 20892-8329, 240-276-6373, 
bielatk@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Radioprotector/Mitigator Development to Decrease Normal 
Tissue Injury During Radiotherapy.
    Date: June 13, 2013.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W302, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Viatcheslav A Soldatenkov, MD, Ph.D., Scientific 
Review Officer, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W254, Bethesda, MD 20892-8329, 240-276-6378, 
soldatenkovv@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Development of a Molecular Diagnostic Assay to Detect Basal-
like Breast Cancer.
    Date: June 13, 2013.
    Time: 12:00 p.m. to 1:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 9609 Medical Center Drive, 
Room 6W032, Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Sonya Roberson, Ph.D., Health Scientist 
Administrator, Resources and Training Review Branch, Division Of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W116, Bethesda, MD 20892-8328, 240-276-6347, 
robersos@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Process Analytic Technologies (PAT) for Biologics: Innovative 
Methods for Monitoring and Analyzing Product Quality.
    Date: June 19, 2013.
    Time: 9:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 9609 Medical Center Drive, 
Room 2W034, Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Thomas A. Winters, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W268, Bethesda, MD 20892-8328, 240-276-6386, 
twinters@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 7, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-11345 Filed 5-13-13; 8:45 am]
BILLING CODE 4140-01-P